Zidebactam restores sulbactam susceptibility against carbapenem-resistant Acinetobacter baumannii isolates
Carbapenems are commonly used to treat infections caused by multidrug-resistant (MDR) bacteria. Unfortunately, carbapenem resistance is increasingly reported in many gram-negative bacteria, especially Acinetobacter baumannii. Diazabicyclooctane (DBO) β-lactamase inhibitors, such as avibactam (AVI),...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2022-07-01
|
| Seri Bilgileri: | Frontiers in Cellular and Infection Microbiology |
| Konular: | |
| Online Erişim: | https://www.frontiersin.org/articles/10.3389/fcimb.2022.918868/full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|